Covid-19 Associated Spontaneous Subdural Hematoma: A Case Report

Authors

Muhammad Sharjeel Sadiq

Medical Officer, HITEC Institute of Medical Sciences

Muhammad Hissan Raza

4th Year Student, HITEC Institute of Medical Sciences

Muhammad Moeed Azwar Bhatti

House Officer, HITEC Institute of Medical Sciences

Mohammad Hassan Yousaf

Lecturer, International Islamic Medical College

Syed Waseem Akhtar

Professor, Department of Neurology, HITEC Institute of Medical Sciences

Abstract

Since March 2020, the health community, all over the world, has faced risks posed by the Coronavirus disease 2019 (COVID-19) pandemic. Worldwide, many reports show that coronavirus-related diseases bring together symptoms affecting both the brain and the vascular system. We describe a case where a young male with COVID-19 developed a spontaneous subdural hematoma 02 weeks after the infection started without having any history of cerebral or vascular injuries. The patient was admitted after testing positive for COVID-19. On the third day of isolation, the patient complained of a severe headache. On CT brain, a subdural hematoma was seen. The patient underwent an emergency craniotomy with satisfactory results. After surgery, he made smooth progress and was discharged a week later. Subdural hematoma is one of the hemorrhagic events that can occur after COVID-19 infection. Any COVID-19 patient who exhibits symptoms of altered consciousness needs to have a brain CT or MRI, and further neurological examination must be done.
Keywords: Coronavirus, Coronavirus disease 2019, COVID-19, Spontaneous Subdural Hematoma, Subdural Hematoma.

How to cite this article

Haider SMA, Sadiq MS, Abdullah MS, Qamar MM, Raza MH, Bhatti MMA, Yousaf MH, Akhtar SW. COVID-19 Associated Spontaneous Subdural Hematoma: A Case Report. HMDJ. 2025 December; 05(02): 79-81.

DOI: https://doi.org/10.69884/hmdj.5.2.9137

References

1. Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, et al. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper. J Glob Infect Dis. 2020;12(2):47–93.
2. Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020 Sep;5(3):279–84.
3. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19 associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020 Aug;296(2):E119–20.
4. Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. Journal of Alzheimer’s Disease. 2020 Jun 30;76(1):3–19.
5. Rothstein A, Oldridge O, Schwennesen H, Do D, Cucchiara BL. Acute Cerebrovascular Events in Hospitalized COVID-19 Patients. Stroke. 2020 Sep;51(9).
6. Gogia B, Fang X, Rai P. Intracranial Hemorrhage in a Patient With COVID-19: Possible Explanations and Considerations. Cureus. 2020 Aug 31;
7. Altschul DJ, Unda SR, de La Garza Ramos R, Zampolin R, Benton J, Holland R, et al. Hemorrhagic presentations of COVID-19: Risk factors for mortality. Clin Neurol Neurosurg. 2020 Nov;198:106112.
8. Cheruiyot I, Sehmi P, Ominde B, Bundi P, Mislani M, Ngure B, et al. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients. Neurological Sciences. 2021 Jan 3;42(1):25–33.
9. Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020 May;35:100669.
10. Dorgalaleh A. Bleeding and Bleeding Risk in COVID-19. Semin Thromb Hemost. 2020 Oct 8;46(07):815–8.
11. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020 Apr;18(4):844–7.

PDF